Biology Reference
In-Depth Information
Spence S, Rena G, Sweeney G, Houslay MD (1995) Induction of Ca
2+
/calmodulin-stimulated
cyclic AMP phosphodiesterase (PDE1) activity in Chinese hamster ovary cells (CHO) by
phorbol 12-myristate 13-acetate and by the selective overexpression of protein kinase
C isoforms. Biochem J 310:975-982
Spence S, Rena G, Sullivan M, Erdogan S, Houslay MD (1997) Receptor-mediated stimulation of
lipid signalling pathways in CHO cells elicits the rapid transient induction of the PDE1B
isoform of Ca
2+
/calmodulin-stimulated cAMP phosphodiesterase. Biochem J 321:157-163
Srivani P, Usharani D, Jemmis ED, Sastry GN (2008) Subtype selectivity in phosphodiesterase
4 (PDE4): a bottleneck in rational drug design. Curr Pharm Des 14:3854-3872
Steiner MK, Preston IR, Klinger JR, Hill NS (2005) Pulmonary hypertension: inhaled nitric oxide,
sildenafil and natriuretic peptides. Curr Opin Pharmacol 5:245-250
Stellato C (2004) Post-transcriptional and nongenomic effects of glucocorticoids. Proc Am Thorac
Soc 1:255-263
Stewart AG (2001) Airway wall remodelling and hyperresponsiveness: modelling remodelling
in vitro and in vivo. Pulm Pharmacol Ther 14:255-265
Sun B, Li H, Shakur Y, Hensley J, Hockman S, Kambayashi J, Manganiello VC, Liu Y (2007)
Role of phosphodiesterase type 3A and 3B in regulating platelet and cardiac function using
subtype-selective knockout mice. Cell Signal 19:1765-1771
Thompson PE, Manganiello V, Degerman E (2007) Re-discovering PDE3 inhibitors - new
opportunities for a long neglected target. Curr Top Med Chem 7:421-436
Thomson NC, Spears M (2005) The influence of smoking on the treatment response in patients
with asthma. Curr Opin Allergy Clin Immunol 5:57-63
Thomson NC, Chaudhuri R, Livingston E (2004) Asthma and cigarette smoking. Eur Respir
J 24:822-833
Thomson NC, Shepherd M, Spears M, Chaudhuri R (2006) Corticosteroid insensitivity in
smokers with asthma: clinical evidence, mechanisms, and management. Treat Respir Med 5:
467-481
Timms RM, Khaja FU, Williams GW (1985) Hemodynamic response to oxygen therapy in chronic
obstructive pulmonary disease. Ann Intern Med 102:29-36
Tiwari S, Dong H, Kim EJ, Weintraub L, Epstein PM, Lerner A (2005) Type 4 cAMP
phosphodiesterase (PDE4) inhibitors augment glucocorticoid-mediated apoptosis in B cell
chronic lymphocytic leukemia (B-CLL) in the absence of exogenous adenylyl cyclase stimu-
lation. Biochem Pharmacol 69:473-483
Torphy TJ (1998) Phosphodiesterase isozymes: molecular targets for novel antiasthma agents.
Am J Respir Crit Care Med 157:351-370
Torphy TJ, Zhou HL, Burman M, Huang LB (1991) Role of cyclic nucleotide phosphodiesterase
isozymes in intact canine trachealis. Mol Pharmacol 39:376-384
Torphy TJ, Undem BJ, Cieslinski LB, Luttmann MA, Reeves ML, Hay DW (1993) Identification,
characterization and functional role of phosphodiesterase isozymes in human airway smooth
muscle. J Pharmacol Exp Ther 265:1213-1223
Ukena D, Harnest U, Sakalauskas R, Magyar P, Vetter N, Steffen H, Leichtl S, Rathgeb F, Keller
A, Steinijans VW (1997) Comparison of addition of theophylline to inhaled steroid with
doubling of the dose of inhaled steroid in asthma. Eur Respir J 10:2754-2760
Vergne F, Bernardelli P, Chevalier E (2005) PDE7 inhibitors: chemistry and potential therapeutic
utilites. Ann Rev Med Chem 40:227-241
Vijayakrishnan L, Rudra S, Eapen MS, Dastidar S, Ray A (2007) Small-molecule inhibitors of
PDE-IV and -VII in the treatment of respiratory diseases and chronic inflammation. Expert
Opin Investig Drugs 16:1585-1599
Wang Z, Malone MH, Thomenius MJ, Zhong F, Xu F, Distelhorst CW (2003) Dexamethasone-
induced gene 2 (dig2) is a novel pro-survival stress gene induced rapidly by diverse apoptotic
signals. J Biol Chem 278:27053-27058
Wenzel S (2003) Pathology of difficult asthma. Paediatr Respir Rev 4:306-311
